
Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve standalone unaudited financial results for the quarter ended on 30th June, 2025.
Filed with BSE ·

Jenburkt Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve standalone unaudited financial results for the quarter ended on 30th June, 2025.
6ix hasn’t read this filing yet.
Jenburkt Pharmaceuticals Ltd on 6ix
Follow Jenburkt Pharmaceuticals into a list and get an email when it puts out news.
Follow Jenburkt Pharmaceuticals